ArticleBMC medicine2021

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC.

Yiting Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.